CombiGene AB(DE:COJ0)
€0.16-0.00 (-1.88%)
DE:COJ0
CombiGene AB financials statements
€0.16
At close:-0.00 (-1.88%)
CombiGene AB (COJ0) Ratios
0 Followers
CombiGene AB Ratios
DE:COJ0's free cash flow for Q2 2026 was kr352.00K. For the 2026 fiscal year, DE:COJ0's free cash flow was increased by kr0.00 and operating cash flow was kr352.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.37 | 17.47 | 24.84 | 22.83 | 18.21 |
| Quick Ratio | 5.37 | 17.47 | 24.84 | 22.83 | 18.21 |
| Cash Ratio | 2.09 | 17.15 | 24.41 | 21.61 | 17.22 |
| Solvency Ratio | -5.30 | -7.41 | -8.50 | -0.96 | 2.97 |
| Operating Cash Flow Ratio | -10.31 | -6.96 | -7.35 | -2.73 | 2.78 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 5.42M | kr 70.82M | kr 99.08M | kr 133.12M | kr 136.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.02 | 1.06 | 1.04 | 1.04 | 1.05 |
| Debt Service Coverage Ratio | -86.59 | 0.00 | -7493.44 | -3482.16 | 0.00 |
| Interest Coverage Ratio | -156.34 | 0.00 | -8039.99 | -4130.20 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.36 | 2.16 | 2.82 | 22.50 | -5.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -14349.69% | -384.04% | -71.91% | 18.04% |
| EBIT Margin | 0.00% | -14484.05% | -654.85% | -23.06% | 24.95% |
| EBITDA Margin | 0.00% | -10496.93% | -648.92% | -21.94% | 28.03% |
| Operating Profit Margin | 0.00% | -14484.05% | -696.25% | -26.02% | 24.95% |
| Pretax Profit Margin | 0.00% | -13766.26% | -643.31% | -23.06% | 24.95% |
| Net Profit Margin | 0.00% | -13766.26% | -643.31% | -23.06% | 24.95% |
| Continuous Operations Profit Margin | 0.00% | -13766.26% | -643.31% | -23.06% | 24.95% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.25% | 95.04% | 92.40% | 88.63% | 100.00% |
| Return on Assets (ROA) | -21.79% | -59.14% | -29.57% | -3.89% | 12.61% |
| Return on Equity (ROE) | -22.27% | -62.70% | -30.63% | -4.05% | 13.25% |
| Return on Capital Employed (ROCE) | -23.38% | -65.97% | -33.15% | -4.57% | 13.25% |
| Return on Invested Capital (ROIC) | -23.38% | -65.97% | -33.15% | -4.57% | 13.25% |
| Return on Tangible Assets | -21.79% | -59.14% | -34.26% | -4.42% | 14.50% |
| Earnings Yield | -27.62% | -95.23% | -66.96% | -3.40% | 10.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 4.60 | 0.00 | 0.00 |
| Payables Turnover | 226.78 | 0.00 | 33.57 | 25.67 | 20.40 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.48 | 6.52 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.05 | 0.17 | 0.51 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.05 | 0.20 | 0.91 |
| Cash Conversion Cycle | -1.61 | 0.00 | 68.49 | -14.22 | -17.89 |
| Days of Sales Outstanding | 0.00 | 0.00 | 79.36 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1.61 | 0.00 | 10.87 | 14.22 | 17.89 |
| Operating Cycle | 0.00 | 0.00 | 79.36 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.65 | -1.51 | -1.54 | -0.84 | 1.28 |
| Free Cash Flow Per Share | -0.65 | -1.51 | -1.55 | -0.84 | 1.27 |
| Dividend Paid and CapEx Coverage Ratio | -3.23 | 0.00 | -280.60 | 0.00 | 149.70 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -280.60 | 0.00 | 149.70 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -91.87 | -5.51 | -0.62 | 0.26 |
| Free Cash Flow Yield | -28.56% | -63.55% | -57.57% | -9.21% | 11.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.65 | -1.05 | -1.49 | -29.39 | 9.41 |
| Price-to-Sales (P/S) Ratio | 0.00 | 144.56 | 9.61 | 6.78 | 2.35 |
| Price-to-Book (P/B) Ratio | 0.81 | 0.66 | 0.46 | 1.19 | 1.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.50 | -1.57 | -1.74 | -10.86 | 8.98 |
| Price-to-Operating Cash Flow Ratio | -3.50 | -1.57 | -1.74 | -10.86 | 8.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.04 | -0.00 | 0.23 | -0.07 |
| Enterprise Value Multiple | -5.87 | 0.78 | 1.34 | -8.40 | 2.57 |
| Enterprise Value | 42.16M | -26.62M | -48.18M | 49.20M | 60.60M |
| EV to EBITDA | -5.87 | 0.78 | 1.34 | -8.40 | 2.57 |
| EV to Sales | 0.00 | -81.66 | -8.69 | 1.84 | 0.72 |
| EV to Free Cash Flow | -3.30 | 0.89 | 1.57 | -2.95 | 2.76 |
| EV to Operating Cash Flow | -3.30 | 0.89 | 1.58 | -2.95 | 2.74 |
| Tangible Book Value Per Share | 2.80 | 3.61 | 5.05 | 6.72 | 7.90 |
| Shareholders’ Equity Per Share | 2.80 | 3.61 | 5.88 | 7.68 | 9.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.02 | 0.28 | 1.35 | 4.85 |
| Net Income Per Share | -0.62 | -2.27 | -1.80 | -0.31 | 1.21 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.95 | 0.95 | 0.98 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 44.60 | 0.00 | 0.00 | 0.65 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.98 | 0.67 | 0.86 | 2.40 | 1.05 |
Currency in SEK

